Thomas J. Bowen

2.0k total citations
22 papers, 770 citations indexed

About

Thomas J. Bowen is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Thomas J. Bowen has authored 22 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Hematology and 3 papers in Molecular Biology. Recurrent topics in Thomas J. Bowen's work include Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and T-cell and Retrovirus Studies (2 papers). Thomas J. Bowen is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and T-cell and Retrovirus Studies (2 papers). Thomas J. Bowen collaborates with scholars based in Canada and United States. Thomas J. Bowen's co-authors include Thomas Kinsella, M J Fritzler, Hans D. Ochs, Leonard C. Altman, Ralph Wedgwood, William D. Perkins, Seymour J. Klebanoff, Roy C. Page, Bernard Babior and Dennis E. Van Epps and has published in prestigious journals such as Nature Communications, PEDIATRICS and Analytical Biochemistry.

In The Last Decade

Thomas J. Bowen

22 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Bowen Canada 13 236 193 146 139 118 22 770
Ian E. Addison United Kingdom 17 336 1.4× 128 0.7× 50 0.3× 52 0.4× 148 1.3× 41 784
Peter Häusermann Switzerland 22 312 1.3× 169 0.9× 61 0.4× 20 0.1× 116 1.0× 49 1.1k
Heikki Isomäki Finland 9 193 0.8× 190 1.0× 38 0.3× 20 0.1× 572 4.8× 15 1.1k
Sungnack Lee South Korea 19 124 0.5× 140 0.7× 43 0.3× 29 0.2× 372 3.2× 60 1.1k
Susumu Yasuoka Japan 20 220 0.9× 198 1.0× 30 0.2× 15 0.1× 96 0.8× 55 1.1k
Noriko Sugita Japan 20 517 2.2× 35 0.2× 216 1.5× 692 5.0× 175 1.5× 55 1.4k
Myew–Ling Toh France 18 541 2.3× 174 0.9× 91 0.6× 14 0.1× 245 2.1× 23 1.0k
C. Leonardi United States 26 1.6k 6.6× 221 1.1× 49 0.3× 39 0.3× 344 2.9× 57 2.1k
A-K Ulfgren Sweden 7 249 1.1× 50 0.3× 24 0.2× 37 0.3× 422 3.6× 12 813
Teresa Carbone Italy 13 819 3.5× 64 0.3× 44 0.3× 23 0.2× 147 1.2× 40 1.3k

Countries citing papers authored by Thomas J. Bowen

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Bowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Bowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Bowen more than expected).

Fields of papers citing papers by Thomas J. Bowen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Bowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Bowen. The network helps show where Thomas J. Bowen may publish in the future.

Co-authorship network of co-authors of Thomas J. Bowen

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Bowen. A scholar is included among the top collaborators of Thomas J. Bowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Bowen. Thomas J. Bowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tardelli, Matteo, Kristal Maner-Smith, Thomas J. Bowen, et al.. (2023). Ligand dependent interaction between PC-TP and PPARδ mitigates diet-induced hepatic steatosis in male mice. Nature Communications. 14(1). 2748–2748. 8 indexed citations
2.
Byrd-Leotis, Lauren, Yi Lasanajak, Thomas J. Bowen, et al.. (2021). SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung. Virology. 562. 142–148. 14 indexed citations
3.
Zhu, Yuyang, Thomas J. Bowen, & Xuezheng Song. (2020). Preparative scale purification of natural glycans by closed-loop recycle HPLC. Analytical Biochemistry. 599. 113702–113702. 8 indexed citations
4.
Bagshaw, Sean M., et al.. (2003). Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Annals of Allergy Asthma & Immunology. 90(5). 572–575. 14 indexed citations
5.
Russell, JA, A Chaudhry, Karen Booth, et al.. (2000). Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. Biology of Blood and Marrow Transplantation. 6(2). 109–114. 50 indexed citations
7.
Russell, Jeffrey A., Christopher Brown, Thomas J. Bowen, et al.. (1996). Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation.. PubMed. 17(5). 703–8. 64 indexed citations
8.
Santisteban, Inés, F X Arredondo-Vega, S Kelly, et al.. (1995). Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Human Molecular Genetics. 4(11). 2081–2087. 45 indexed citations
9.
Parsons, Hannah, Floyd F. Snyder, Thomas J. Bowen, John S. Klassen, & Antonio Pinto. (1995). Immune complex disease consistent with systemic lupus erythematosus in a patient with lysinuric protein intolerance. Journal of Inherited Metabolic Disease. 19(5). 627–634. 12 indexed citations
10.
Matheson, David S., Thomas J. Bowen, Anne Junker, et al.. (1994). Production of factors with B-cell growth and differentiation activities by peripheral blood mononuclear cells from patients with hypogammaglobulinemia. Journal of Allergy and Clinical Immunology. 93(1). 126–135. 2 indexed citations
11.
Coupland, Stuart G., Curtis W. Ponton, Jos J. Eggermont, Thomas J. Bowen, & Ronald Grant. (1991). Assessment of cisplatin-induced ototoxicity using derived-band ABRs. International Journal of Pediatric Otorhinolaryngology. 22(3). 237–248. 12 indexed citations
12.
McGarry, Ronald C., et al.. (1989). Recognition of an in vivo immune response to human neuroblastoma modulation of antigen expression by retinoic acid. Medical and Pediatric Oncology. 17(5-6). 459–465. 2 indexed citations
13.
Matheson, David S., et al.. (1987). Humoral immune response in patients with hemophilia. Clinical Immunology and Immunopathology. 44(1). 41–50. 13 indexed citations
14.
Matheson, David S., et al.. (1986). T Lymphocytes from Hemophiliacs Proliferate after Exposure to Factor VIII Product. Vox Sanguinis. 51(2). 92–95. 17 indexed citations
15.
Kelly, James K., Alfredo Pinto, William A. Whitelaw, et al.. (1986). Fatal Aspergillus Pneumonia in Chronic Granulomatous Disease. American Journal of Clinical Pathology. 86(2). 235–240. 20 indexed citations
16.
Lewkonia, R M & Thomas J. Bowen. (1986). Familial concurrence of pauciarticular syndrome and systemic sclerosis. Clinical Rheumatology. 5(2). 252–255. 1 indexed citations
17.
Fritzler, M J, et al.. (1985). Antinuclear, anticytoplasmic, and anti-Sjogren's Syndrome antigen A (SS-A/Ro) antibodies in female blood donors. Clinical Immunology and Immunopathology. 36(1). 120–128. 141 indexed citations
18.
Bowen, Thomas J., Ralph Wedgwood, Hans D. Ochs, & Werner Henle. (1983). Transient Immunodeficiency During Asymptomatic Epstein-Barr Virus Infection. PEDIATRICS. 71(6). 964–967. 8 indexed citations
19.
Page, Roy C., Thomas J. Bowen, Leonard C. Altman, et al.. (1983). Prepubertal Periodontitis. I. Definition of a Clinical Disease Entity,. Journal of Periodontology. 54(5). 257–271. 136 indexed citations
20.
Bowen, Thomas J. & H Pabst. (1976). Immunologic response in vitro after thymechtomy in patients with myasthenia gravis.. PubMed. 115(7). 619–22. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026